header logo image


Page 441«..1020..440441442443..450460..»

Man fears he could be left homeless as well as blind in one eye after ‘attack’ in Lincoln – LincolnshireLive

August 22nd, 2020 3:52 pm

A man who has been told he may be permanently blinded in one eye after he was struck with glass in Lincoln fears he may also be left homeless.

Kane Lilleyman suffered a serious injury to his eye after he was allegedly attacked in Baggholme Road close to the junction with Croft Street in the Monks Road area at around 11pm on July 28.

And if the thought of never regaining his vision in one eye wasnt enough to comprehend, the 29-year-old is now seriously concerned that he could soon be without a roof over his head.

Mr Lilleyman owns and lives on a houseboat, but is what he calls a continuous cruiser meaning he has to keep moving the boat because he doesnt have a place to permanently moor the vessel.

However, the loss of his sight means he no longer feels able to move the boat safely and it is has also meant he has had to give up his job of jewellery making.

As a result of not moving the boat, he is infringing the terms of his boating licence and because he can no longer do his job, he doesnt have the income to be able to fund the money needed for a permanent mooring.

He told Lincolnshire Live : I am too scared to move it [the boat] because I cant tell how far the bank is from my boat, so when it comes to parking I cant tell if Im close enough to jump off or if I am too close to risk sinking via crashing.

I could face losing my boat because Ill be breaching the terms of my licence and now that Ive lost all forms of my income, I cannot afford to get a home registered mooring for the boat.

I am stuck in an extremely anxious catch 22 position and I cant see any way out of this mess.

Mr Lilleyman says it is hard not to get down as his injury has completely changed his life.

He said: I am depressed and very anxious because I am unable to move my houseboat and I have to move it by law to keep in accordance with my licence.

I am unable to continue with my jewellery making because I have no depth perception.

I cant ride my motorcycle anymore either because it is my traffic side that has been damaged.

On the whole I am pretty depressed. This has ruined most aspects of my life.

Friends have stepped in to help and have set up a Gofundme page to raise the money needed to pay the licence fees and avoid the boat being confiscated as well as then the funds for a permanent mooring.

Mr Lilleyman says he is praying the situation can be sorted as he cant bear the thought of having to give up his dream life on the water.

He said: If I cant get a permanent mooring, Ill be forced to sell the boat.

I cant face living on land. Ive been here for eight years and the water means absolutely everything to me.

Police are investigating the incident that led to Mr Lilleymans injury.

A man has been arrested on suspicion of GBH with intent but has been released pending further investigation.

A force spokesperson said: A 29-year-oldmanwas struck by a glass on Baggholme Road at the junction with Croft Street at 11pm on July 28.

The victim sustained an injury to his eye and it is thought he will not regain his sight.

This is an active police investigation and a 19-year-oldmanwas arrested. He has since been released under investigation.

Any witnesses to this incident should call 101 quoting incident 513 of July 28. To make an anonymous report, please contact CrimeStoppers.

To view the Gofundme page click here

Continue reading here:
Man fears he could be left homeless as well as blind in one eye after 'attack' in Lincoln - LincolnshireLive

Read More...

Why we are suffering more from eye strain, and how to help prevent it – Clacton and Frinton Gazette

August 22nd, 2020 3:52 pm

AN opticians is advising residents to look after their eyesight as a socially distanced work and social life means more time spent looking at screens.

Scrivens Opticians and Hearing Care, in Dovercourt, is encouraging locals to get their eyes tested after 57 per cent of people it surveyed said eye strain has been a side effect from living a virtual life during the coronavirus pandemic.

The study - carried out by OnePoll - also found many people aged 55 and over needed to re-evaluate their approach to looking after their vision.

Results showed just a fifth of those in this age group were concerned about the possible side effects of blue light on their vision - compared to half of those aged 18 to 24.

Blue light is a colour in the visible light spectrum that can be seen by human eyes - it is all around us.

The light produces higher amounts of energy and can cause eye strain, physical and mental fatigue and headaches for prolonged use of electronic devices or computers.

Claire Lethbridge, branch manager, said: As we are spending much more time using screens to communicate with colleagues, friends and family, the strain on our eyes is intense, so its vital that we give as much priority to booking an eye test as we do to taking up half price meal offers.

The same study revealed that half of the 2,000 people polled are apprehensive about booking an appointment in the wake of the pandemic.

Ms Lethbridge added: We have taken every possible precaution to make sure our store is safe for customers and for staff too.

Its so important that we take care of our eyesight and go for regular checks every two years, as they are the window to our general health too, as an eye test can detect so much more than a deterioration in our vision.

Tips for avoiding eye strain:

View post:
Why we are suffering more from eye strain, and how to help prevent it - Clacton and Frinton Gazette

Read More...

Candle Lit Tour and New Outdoor Exhibits Coming to the Baldwin Home Museum – Maui Time

August 22nd, 2020 3:51 pm

The new sports exhibit shows off some of Lahainas Pioneer Mill era sports teams.

Come take a step back into Lahainas past as Candle Lit Tours return to the Baldwin Home Museum starting Friday, Sept. 4 from 5 8 pm, alongside a new, free Pioneer Mill era sports exhibit. The tours and exhibits will be held weekly in conjunction with Friday Night is Art Night.

The Candle Lit Tour explores the fully furnished 19thcentury Baldwin Home which will be illuminated by dozens of candles. Tours are $5 per person with children 12 and under free. Each 20 minute tour is limited to 5 people. Signups will be taken on site. Docents will walk each group through the home, and once they are back outside, questions will be taken. The docents of the popular tour are excited for a return to educating the public, and invite the community to take a step back into time.

A free exhibit featuring photographs of a variety of sports teams from the Pioneer Mill era will be on display on the Baldwin Home lawn. The exhibit shows off the many memories of youth, club and community sports from the 1930s to the 1970s.

The public is invited to stroll through Historic Lahaina Town for the festive Friday Night is Art Night. Visitwww.LahainaRestoration.org for a list of participating galleries.

In conformance with Maui County regulations, masks must be worn on the candle lit tour and while looking at the outdoor exhibits. Single use masks, and hand sanitizer will be available on site and social distancing will be enforced. Please be conscious of the safety and comfort of yourself and others when attending.

Contactevents@lahainarestoration.orgfor more information

Press Release and Image courtesy Lahaina Restoration Foundation

comments

Read the original post:
Candle Lit Tour and New Outdoor Exhibits Coming to the Baldwin Home Museum - Maui Time

Read More...

Deals Under the Radar: These Are the Israeli Tech Companies Already Operating in the UAE – Algemeiner

August 22nd, 2020 3:51 pm

A general view of ADNOC headquarters in Abu Dhabi, United Arab Emirates May 29, 2019. Photo: REUTERS/Christopher Pike/File Photo.

CTech Im very active on LinkedIn, I have tens of thousands of contacts and I receive around 10 new requests a day, but something weird happened last Friday. I was swamped with new follower requests. I thought my account was hacked, but when I began looking through the names and the accounts analytics I saw that they were all businessmen and senior executives from insurance companies in the United Arab Emirates, Yariv Yanay, Director of Business Development and Innovation at Hachshara Insurance Company, told Calcalist.

Yanay is one of the founders of the go Digital Insurance application developed by Hachshara for digital car insurance. I approved all the requests and already set Zoom meetings with them. They ask serious questions that show that they know what they need from us. A representative from a big insurance company there asked me a very specific question about one of our developments in UBI (usage-based insurance) while someone else was interested in learning about dealing with claims digitally, and another inquired if the product suits a B2C market. It was apparent that they had done their homework.

Israel has become an insurtech powerhouse in recent years, even though local consumers arent aware of the services being offered by many of the companies.

Right now, I feel like they are checking us out because they have heard that Israel is an insurtech superpower, noted Yanay. The potential isnt just in the possible sale of products to the UAE, but that this can also lay the infrastructure for entering the rest of the Arab world and places like Jordan and Egypt. I take part in many international conferences and until now it was very obvious we were outcasts.

August 22, 2020 10:39 am

By complete coincidence, Yarivs brother, the CEO and President of biomed company Pluristem, announced on Monday that the regenerative medicine company developing a platform of novel biological therapeutic products has signed a non-binding Memorandum of Understanding (MOU) with the UAE-based Abu Dhabi Stem Cells Center (ADSCC), a specialist healthcare center focused on cell therapy and regenerative medicine.

Alongside insurtech and biomedicine, the fintech sector has also generated plenty of interest in the UAE. The Israeli fintech sector, which includes 530 startups, attracted record funding of $2 billion during 2019. This looks like a match made in heaven, said Shmulik Ben-Tovim, president of the Fintech Community of Israel. While Israel is regarded as a tech powerhouse, but an undeveloped financial center, in Dubai there is the exact opposite situation. Israeli fintech companies will literally be entering a desert.

Israel nowadays is mainly known in the Gulf states for its aesthetics medical innovation as Dubai and Abu Dhabi have a young and rich population, noted Adi Nov, deputy manager at ICIC-Israel Credit Insurance Company. Another strong sector is agtech, specifically irrigation technology. There is also business in the plastic industry and some fashion, mainly swimwear and underwear.

According to Paris-based insurance company Euler Hermes, which holds shares in ICIC, Israels areas of expertise are similar to those of the US which is the third-largest exporter to the UAE after China and India and is responsible for 10% of the imports in the weapons and tech sectors.

Israels tech companies werent waiting around for Donald Trumps announcement that Israel and the UAE had agreed to normalize ties, with many companies doing business in the region for several years. Most of them do so via a local distributor, but companies like Cybereason, which is based out of the US, have offices in the UAE.

The UAE is a very special and significant market, said Shai Horovitz, Chief Revenue Officer at Cybereason. The leading investor in Cybereason is the Vision Fund, with half of its $100 billion under management coming in from the Persian Gulf and Saudi Arabia. As a result, the Israeli cyber company has relationships in the region dating back many years.

There are several Israeli cybersecurity companies currently operating successfully in the UAE, including Check Point, which states on its website that it has representation in Dubai; CyberArk, which works with a local distributor; and IntSights, which has significant sales in the region.

There is a clear need for cybersecurity products due to geopolitical reasons. The Emirates encounter the same threats that our western clients are facing. The same actors that threaten large financial institutions and government agencies in Europe and the US are also acting against the UAEs interests, explained Horovitz.

Guy Nizan, co-founder and CEO of IntSights, said that Israeli tech is received very well in the region. It is an advantage because the client recognizes Israeli tech as a brand. Moreover, they understand the importance of security and are willing to invest a lot in the sector.

And it isnt just Israeli cybersecurity that is prospering in Dubai. There are several other Israeli tech companies that have made a name for themselves, including Cato Networks, whose core product is a cloud service and operates a server farm in Dubai. Israeli giant Monday.com has also become well known in the UAE over the past three years and is partnering with several companies in the region.

We have over 700 clients in the Persian Gulf and over the last year the company increased its sales in the region by 300% and is planning on reaching sales of $5 million by the end of 2021, said Barak Zigdon, partnerships and global resellers manager at Monday.com. Software company JFron is also selling to clients in the UAE.

One sector with great potential in the area is agtech, mainly due to the dry climate in both Israel and the UAE.

We have been talking to different actors in the UAE about promoting desert agriculture projects, said Or Haviv, partner and head of ventures at Arieli Capital. There is no done deal, but we were already discussing it prior to last weeks announcement. The UAE wants to learn how to do agriculture in the desert and gain produce which is at the level of that grown in Israel. There is a plan to send a delegation from the UAE to Israel so that they can undergo training at Ramat Negev.

Alan Feld, co-founder and managing partner at Vintage Investment Partners, believes that the UAE is open to investing in Israeli tech in addition to purchasing its products. I believe that we will very soon see investments in VCs and Israeli companies. They have a VC industry and they also want us to invest in their companies.

The entire region is a desert and in the middle of it they built an amazing airport and one of the best tourism systems Ive seen, added Feld, who was in the UAE in February. They want to diversify their sources of income and not be so dependent on the price of oil. They see themselves as a regional technology center and Israel is a good source of technology for them.

Boaz Dinte, managing general partner at Qumra Capital, added: Over the past two years we have received more and more approaches from people in the region who are interested in investing in Israeli funds and Israel in general. From a personal standpoint, I was a little wary as I didnt know what the consequences would be for the fund if we received money from the Gulf. I was uncertain what it would mean and if it would put constraints on the fund, but now it has clearly become legitimate.

Read the original:
Deals Under the Radar: These Are the Israeli Tech Companies Already Operating in the UAE - Algemeiner

Read More...

Book Review: What Can India’s Embrace of Nanotech Tell Us About India’s Science? – The Wire Science

August 21st, 2020 11:59 am

A glass nanoparticle suspended in an optical cavity. Photo: uclmaps/Flickr, CC BY 2.0.

Nanotechnology may not be a familiar term to many although nanotechnology-based products are available in the market and many consumers use them. Thanks to Nano Mission, an initiative funded by the Government of India through the Department of Science and Technology from May 2007, India has made great strides in nanosciences and engineering.

In this regard, Nanoscale, a new book by Pankaj Sekhsaria, a policy researcher at the Centre for Technology Alternatives for Rural Areas, IIT Bombay, doesnt eulogise the technology and its achievements nor does it criticise them and their deployment and risks.

Instead, Sekhsaria takes an atypical tack to set out what is possible, offering us new ways to conceive of and evaluate research. Through four case studies, he attempts to understand the links between science, technology and society at different sites and at different scales as if to ensure we are aware of what all is possible before we embark on our respective critical journeys. They are:

1. Developing a cutting-edge microscope at a university in Pune, despite severe constraints

2. Using nanotechnology to validate some components of a traditional Ayurvedic preparation

3. The failure of an innovative product a nano-silver-coated ceramic candle used to purify water in households

4. Nanotechnology-based treatment protocols for retinoblastoma, a cancer that affects children

The first case study concerns the construction of a scanning tunnelling microscope by C.V. Dharmadhikari at the University of Pune, using a variety of materials, including nanoparticles. Sekhsaria describes how Dharmadhikari built this sophisticated device from scratch, indigenously, and which he and his team now use for their research.

With this in mind, Sekhsaria invokes the concept of jugaad and the culture of innovation in laboratories around India. However, Eric von Hippels user innovation theory offers a better explanation: that more innovation is driven by intermediate or end users, at the site of consumption, which is then integrated by suppliers. In this case, Dharmadhikari is both a user and an innovator: he first developed the instrument and then, in the course of using it, continued to make minor modifications to better suit his and his peers purposes.

In fact, this would be true of most scientific instruments which are constantly attended to by a community of user-innovators of PhD students, postdoctoral researchers and investigators. As a result, in an ecosystem where resources are scarce and grants and funds are constantly shadowed by uncertainty, such DIY endeavours contribute more innovation and help adapt sophisticated technologies for more local conditions including nanotechnology.

Sekhsaria subsequently describes the fate of Dharmadhikari et als scanning tunnelling microscope, and compares it to that of similar innovations elsewhere in India. However, he stops short of discussing the range, utility and novelty of such instruments and how they have enabled Indian scientists to pursue science despite their constraints. Nor is there mention of how common such solutions are common across disciplines and institutions. Of course, user innovation can occur even when new instruments are acquired but if building instruments from scratch is very widely practised, it deserves a fuller study, as an important dimension of doing science in India.

The second case study concerns the use of nanotechnological tools to validate the components of a traditional Ayurvedic preparation, called bhasmas, and related work at the Centre for Nanobioscience, Agharkar Research Institute, Pune. Using the studies of Rinku D. Umrani, Sekhsaria highlights how the dialog between modern science (nanotechnology) and traditional medicine (Ayurveda) is necessary, although there are skeptics on both sides.

While the usefulness of traditional medicine is well known and accepted, it is often debunked as unscientific or considered to be scientifically unprovable. But a dialog could help better understand each system from the other systems perspective, paving the way for potentially fruitful collaborations.

With the specific example of bhasmas, Sekhsaria focuses the discussion onto the challenge of checking if Ayurveda can provide an alternative way to manage diabetes. Umranis work suggests that the mechanisms of action of some Ayurvedic preparations, including bhasmas, involve reactions involving nanoparticles. But instead of limiting himself to a yes/no answer, Sekhsaria argues that validation is necessary but a dialog as equals is more important to facilitate further research that, by extension, the introduction of radical new technologies brings with it radical new opportunities to improve the way we organise and conduct research.

Also read: Why Elon Musk Isnt Right About Nanotechnology Being BS

The third case study highlights how an innovation perceived to be locally useful to provide good quality drinking water at the household level using nanosilver-coated candles failed in the market. Researchers at the International Advanced Research Centre for Powder Metallurgy and New Materials (ARCI), Hyderabad, had developed these devices, essentially ceramic candles coated with nanoparticles of silver that could filter out some bacterial species from water.

But for the fact that they were simple to use, required less maintenance and were locally produced, they flopped at the market because they rested on the products uniqueness instead of adjusting for consumer behaviour and aspirations. The ceramic candle platform itself was becoming obsolete as a water purification technology, and newer entrants, ranging from advanced filters to ultraviolet and reverse-osmosis systems, all of which trapped more than bacteria, heightened buyers expectations.

Nonetheless, the candles were still useful, especially in low-cost settings. So Sekhsaria contends that such products shouldnt have been left at the mercy of market forces and that the government should have stepped in with subsidies. In fact, he challenges the idea that nanosilver-coated candles are obsolete per se, and argues that obsolescence is linked to infinite demands and consumption and that ARCI might have had more success if it had involved end-users during the product development process. According to him, there is also scope to recalibrate, renegotiate and revive the product, especially if were willing to learn from our mistakes.

The fourth case study is on treating retinoblastoma in female children. While nanotechnology is expected to offer better solutions like using gold-based nanoparticles to destroy cancer cells in a photothermal process the grim reality is that in some cases, parents prefer not to treat the child and let her die. This is because when children afflicted with retinoblastoma are not treated on time, they may lose eyesight and sometimes even their lives. In this regard, Sekhsaria spotlights how clinicians often talk to these childrens parents as if they are activists, and attempt to educate parents.

There is hardly any categorised data on retinoblastoma in India and how different sections of society have responded to it. It is true that technology is no panacea and the social complexities have to be taken into account but the complexity cant be reduced to that of only discrimination.

Sekhsaria discusses how girls and women are discriminated against, and how some parents choose to ignore new technologies that offer better treatment in favour of letting them die. However, his foundation is almost entirely anecdotal, based on discussions he had in two institutions in Hyderabad and Chennai. His analysis would have been enriched by including examples from more institutions, even if only in these cities, and could have fortified Sekhsarias arguments.

As such, the reader is unable to generalise from his examples as to the fraction of parents in the country who decide thus and why, nor whether the parents of male children behave the same way. Moreover, Sekhsaria discusses only those cases where parents didnt treat the child even if they had the option to do so, or accessed treatment when the retinoblastoma had entered the later stages.

Instead, the discussion could have covered the class and access to treatment dimensions. Unless we know how different sections of society respond to all the options available to them, the books view remains one-dimensional and unable to help us understand the technology-society interface. Nanotechnological solutions are not yet in vogue and are years away from widespread adoption. And even if nanotechnology has to have a positive impact, its success depends on the solutions affordability, accessibility and the decisions of parents who need to decide what is best for their children and themselves.

In fact, overall, Nanoscale often doesnt go far enough to flesh out the stories it uses to make its point about the unique prevalence of nanotechnologies across four very different slices of society, as if the book is attempting to anticipate the nanos outsized impact on society, and even social relations, in future.

Currently, India publishes the third-highest number of research papers on nanotechnology in the world. Nanotechnologies themselves have applications in sectors ranging from agriculture to textiles, from medicine to construction materials. For example, nano-fertilisers can help increase the efficiency with which plants use nutrients in the soil and help reduce nutrient run-off. Researchers have also used precepts of nanotechnology to improve hydrogen-based renewable energy technologies.

Also read: Why India Needs Nanotechnology Regulation Before it is Too Late

In this regard, Nanoscale provides a new perspective on nanotechnology in India and asks important questions about the corresponding science, technology and policies of innovation. Sekhsaria also successfully subverts conventional wisdom on innovation and attempts to link jugaad with sophistication, calls for dialog between modern science and traditional medicine, and highlights how the market can destroy innovations even as it patronises more expensive technology.

As such, Sekhsarias reluctance to pronounce verdicts works to the books advantage because, by highlighting the gap between traditional ideas of innovation in laboratories and the ground reality, he is able to contend that we can utilise nanotechnologies to a fuller extent by applying them to areas where there is a contest of paradigms or worldviews.

Krishna Ravi Srinivas works at Research and Information Systems for Developing Countries, a policy research think-tank. The views expressed here are the authors own.

See the article here:
Book Review: What Can India's Embrace of Nanotech Tell Us About India's Science? - The Wire Science

Read More...

Healthcare Nanotechnology (Nanomedicine) Market Analysis, Key Players, Industry Segments And Forecast To 2026 – The News Brok

August 21st, 2020 11:59 am

The Healthcare Nanotechnology (Nanomedicine) market report 2020-2026 provides in-depth study of market competitive situation, product scope, market overview, opportunities, driving force and market risks. Profile the Top Key Players of Healthcare Nanotechnology (Nanomedicine), with sales, revenue and global market share of Healthcare Nanotechnology (Nanomedicine) are analyzed emphatically by landscape contrast and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is additionally administrated. The Healthcare Nanotechnology (Nanomedicine) market business development trends and selling channels square measure analyzed. From a global perspective, It also represents overall industry size by analyzing qualitative insights and historical data.

Key players operating in the global Healthcare Nanotechnology (Nanomedicine) market includes : Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith&Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International, and among others.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Healthcare Nanotechnology (Nanomedicine) Market @https://www.researchmoz.us/enquiry.php?type=S&repid2041239

Key Target Audience of the Healthcare Nanotechnology (Nanomedicine) market:

Scope of Healthcare Nanotechnology (Nanomedicine) Market:

The global Healthcare Nanotechnology (Nanomedicine) market is valued at million US$ in 2019 and will reach million US$ by the end of 2026, growing at a CAGR of during 2020-2026. The objectives of this study are to define, segment, and project the size of the Healthcare Nanotechnology (Nanomedicine) market based on company, product type, application and key regions.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Healthcare Nanotechnology (Nanomedicine) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Healthcare Nanotechnology (Nanomedicine) market.

The report offers an exhaustive geographical analysis of the global Healthcare Nanotechnology (Nanomedicine) market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The end users/applications and product categories analysis:

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate foreach application.

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, market share and growth rate ofeach type.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid2041239

Healthcare Nanotechnology (Nanomedicine) Market The Regional analysis covers:

Key Findings & Data Available in Healthcare Nanotechnology (Nanomedicine) Market Report:

And Many More.

Get Discount on Healthcare Nanotechnology (Nanomedicine) Market Report :https://www.researchmoz.us/enquiry.php?type=D&repid2041239

Contact Us:

ResearchMozMr. Rohit Bhisey,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email: [emailprotected]Follow us on LinkedIn @ http://bit.ly/2RtaFUo

Follow me on : https://marketnews-24.blogspot.com/

Read more:
Healthcare Nanotechnology (Nanomedicine) Market Analysis, Key Players, Industry Segments And Forecast To 2026 - The News Brok

Read More...

Global Nanotechnology Drug Delivery Market : Industry Analysis and Forecast (2019-2026): By Technology, Application and Region. – Good Night, Good…

August 21st, 2020 11:59 am

Global Nanotechnology Drug Delivery Marketwas valued US$ XX Bn in 2018 and is expected to reach US$ 98.2 Bn by 2026, at a XX% CAGR of around during a forecast period.

Various novel technologies for developing effective drug delivery systems came into existence among which nanotechnology platforms for achieving targeted drug delivery are gaining prominence nowadays. Research in the medical field includes the development of drug nanoparticles, polymeric and inorganic biodegradable nano-carriers for drug delivery, and surface engineering of carrier molecules.

The report contains a detailed list of factors that will drive and restrain the growth of the Nanotechnology Drug Delivery Market. Such as, rapidly expanding areas of research and development to develop novel nano-medicine are expected to drive the nanotechnology drug delivery market growth in the future. Additionally, one of the major factors assisting market growth is the growing prevalence of infectious diseases and cancer, developing nanotechnology research, and increasing demand for novel drug delivery systems. However, high cost coupled with stringent regulatory scenario hinders the market growth to some extent.

Nanoparticles are expected to account for the largest XX% market share by 2026. The segment dominated the market as key nanoparticles like gold nanoparticles, dendrimers, and fullerenes are used in pharmaceutical drug delivery.The report offers a brief analysis of the major regions in the global nanotechnology drug delivery market, namely, APAC, Europe, North America, South America, and the Middle East & Africa. North America dominated the nanotechnology drug delivery market in 2018, because of high medical reimbursement facilities, and technological advancement. The APAC is projected to have the fastest growth, owing to a rapidly increasing population, an increase in consumer awareness, favorable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing economies such as China, and India in this region.

Nanotechnology drug delivery market report gives a competitive analysis of the individual standing of the companies against the global landscape of the medical industry. The forecast also provides the estimated trends in demand for the global market and their impact on the sizes of these companies to help the reader curate profitable business strategies. Such as Pfizer, Inc., AstraZeneca and Amgen signed agreements to collaborate with BIND Therapeutics to develop nano-medicines. These initiatives are expected to fuel the growth of the nanotechnology drug delivery market in the upcoming future.

The objective of the report is to present comprehensive analysis of Global Nanotechnology Drug Delivery Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Nanotechnology Drug Delivery Market dynamics, structure by analyzing the market segments, and project the Global Nanotechnology Drug Delivery Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nanotechnology Drug Delivery Market make the report investors guide.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.Scope of the Global Nanotechnology Drug Delivery Market

Global Nanotechnology Drug Delivery Market, by Technology

Nanocrystals Nanoparticleso Dendrimerso Gold Nanoparticleso Dendrimerso Fullereneso Others Liposomes Micelles Nanotubes OthersGlobal Nanotechnology Drug Delivery Market, by Application

Neurology Oncology Cardiovascular/Physiology Anti-inflammatory/Immunology Anti-infective OthersGlobal Nanotechnology Drug Delivery Market, by Region

North America Asia Pacific Europe Middle East & Africa South AmericaKey players operating in the Global Nanotechnology Drug Delivery Market

Johnson & Johnson Merck & Co Roche Bayer Novartis Pharmaceuticals Pfizer AstraZeneca Amgen Celgene Corporation Angiotech Pharmaceuticals Capsulution Pharma AlphaRx Inc. Calando Pharmaceuticals Copernicus Therapeutics Elan Corporation Nanotherapeutics PAR Pharmaceutica Taiwan Liposome Co. AbbVie, Inc Amgen, Inc

Global Nanotechnology Drug Delivery Market Request For View Sample Report Page : @https://www.maximizemarketresearch.com/request-sample/39035About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:Name: Vikas GodageOrganization: MAXIMIZE MARKET RESEARCH PVT. LTD.Email: sales@maximizemarketresearch.comWebsite:www.maximizemarketresearch.com

See more here:
Global Nanotechnology Drug Delivery Market : Industry Analysis and Forecast (2019-2026): By Technology, Application and Region. - Good Night, Good...

Read More...

Nanotechnology in Medical Market 2020 Explain What is the current size of the market? And key players analysis: Roche, Mitsui Chemicals, Camurus,…

August 21st, 2020 11:59 am

A complete research offering of comprehensive analysis of the market share, size, recent developments, and trends can be availed in this latest report by Big Market Research.

As per the report, theGlobal Nanotechnology in Medical Marketis anticipated to witness significant growth during the forecast period from 2020to 2025.

The report provides brief summary and detailed insights of the market by collecting data from the industry experts and several prevalent in the market. Besides this, the report offers a detailed analysis of geographical areas and describes the competitive scenario to assist investor, prominent players, and new entrants to obtain a major share of the global Nanotechnology in Medical market.

Our analysis involves the study of the market taking into consideration the impact of the COVID-19 pandemic. Please get in touch with us to get your hands on an exhaustive coverage of the impact of the current situation on the market. Our expert team of analysts will provide as per report customized to your requirement. For more connect with us at [emailprotected] or call toll free: +1-800-910-6452

Request a sample of this premium research:https://www.bigmarketresearch.com/request-sample/3962053?utm_source=PF&utm_medium=ANIL

The report presents a summary of each market segment such as type, end-user, applications, and region. With the help of pie charts, graphs, comparison tables, and progress charts a complete overview of the market share, size, and revenue, and growth patterns areaccessible in the report.

Additionally, an outline of each market segments such as end user, product type, application, and region are offered in the report.The market across various regions is analyzed in the report which includes North America, Europe, Asia-Pacific, and LAMEA.The report explains future trends and growth opportunities in every region. These insights help in understanding the global trends in the market and form strategies to be implemented in the future. Moreover, the research report profiles some of the leading companies in the global Nanotechnology in Medical industry. It mentions their strategic initiatives and offers a brief about their business. Some of the players profiled in the global Nanotechnology in Medical market include:

Key players in the Nanotechnology in Medical covers :RocheMitsui ChemicalsCamurusMerckCelgeneCytimmuneAmgenAccessPfizerSmith and NephewNovartisDentsply International3M

Analysts have also stated the research and development activities of these companies and provided complete information about their existing products and services. Additionally, the report offers a superior view over different factors driving or constraining the development of the market.

The Nanotechnology in Medical can be split based on product types, major applications, and important countries as follows:

The basis of applications, the Nanotechnology in Medical from 2015 to 2025 covers:HospitalsClinicsOthers

The basis of types, the Nanotechnology in Medical from 2015 to 2025 is primarily split into:Nano MedicineNano DiagnosisOther

Request a discount on standard prices of this premium research:https://www.bigmarketresearch.com/request-for-discount/3962053?utm_source=PF&utm_medium=ANIL

The report clearly shows that the Nanotechnology in Medical industry has achieved remarkable progress since 2025 with numerous significant developments boosting the growth of the market. This report is prepared based on a detailed assessment of the industry by experts. To conclude, stakeholders, investors, product managers, marketing executives, and other experts in search of factual data on supply, demand, and future predictions would find the report valuable.

The report constitutes:Chapter 1 provides an overview of Nanotechnology in Medical market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Nanotechnology in Medical market by type, application, and region are also presented in this chapter.Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.Chapter 3 provides a full-scale analysis of major players in Nanotechnology in Medical industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.Chapter 4 gives a worldwide view of Nanotechnology in Medical market. It includes production, market share revenue, price, and the growth rate by type.Chapter 5 focuses on the application of Nanotechnology in Medical, by analyzing the consumption and its growth rate of each application.Chapter 6 is about production, consumption, export, and import of Nanotechnology in Medical in each region.Chapter 7 pays attention to the production, revenue, price and gross margin of Nanotechnology in Medical in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.Chapter 9 introduces the industrial chain of Nanotechnology in Medical. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.Chapter 10 provides clear insights into market dynamics.Chapter 11 prospects the whole Nanotechnology in Medical market, including the global production and revenue forecast, regional forecast. It also foresees the Nanotechnology in Medical market by type and application.Chapter 12 concludes the research findings and refines all the highlights of the study.Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:Historical Years: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Period: 2020-2025

About Us:Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact us:Mr. Abhishek Paliwal5933 NE Win Sivers Drive, #205, Portland,OR 97220 United StatesDirect: +1-971-202-1575Toll Free: +1-800-910-6452E-mail:[emailprotected]

See more here:
Nanotechnology in Medical Market 2020 Explain What is the current size of the market? And key players analysis: Roche, Mitsui Chemicals, Camurus,...

Read More...

Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – Good Night, Good Hockey

August 21st, 2020 11:59 am

Nanomedicine Marketwas valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/39223

Nanomedicine is an application of nanotechnology, which are used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine usages nanoscale manipulation of materials to improve medicine delivery. Therefore, nanomedicine has facilitated the treatment against various diseases. The nanomedicine market includes products that are nanoformulations of the existing drugs and new drugs or are nanobiomaterials. The research and development of new devices as well as the diagnostics will become, more effective, enabling faster response and the ability to treat new diseases are likely to boost the market growth.

The nanomedicine markets are driven by factors such as developing new technologies for drug delivery, increase acceptance of nanomedicine across varied applications, rise in government support and funding, the growing need for therapies that have fewer side effects and cost-effective. However, long approval process and risks associated with nanomedicine (environmental impacts) are hampering the market growth at the global level. An increase in the out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are likely to create lucrative opportunities in the nanomedicine market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nanomedicine Market Segmentation Analysis:Based on the application, the nanomedicine market has been segmented into cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. The oncology segment held the dominant market share in 2018 and is projected to maintain its leading position throughout the forecast period owing to the rising availability of patient information and technological advancements. However, the cardiovascular and neurology segment is projected to grow at the highest CAGR of XX% during the forecast period due to presence of opportunities such as demand for specific therapeutic nanovectors, nanostructured stents, and implants for tissue regeneration.

Nanomedicine Market Regional Analysis:Geographically, the Nanomedicine market has been segmented into North America, the Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the Nanomedicine market in 2018 due to the rising presence of patented nanomedicine products, the availability of advanced healthcare infrastructure and the rapid acceptance of nanomedicine. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period thanks to rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, the rising investments in research and development activities for the introduction of advanced therapies and drugs are predicted to accelerate the growth of this region in the near future.

Nanomedicine Market Competitive landscapeMajor Key players operating in this market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc, and Johnson & Johnson. Manufacturers in the nanomedicine are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

The objective of the report is to present a comprehensive analysis of Nanomedicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Nanomedicine Market dynamics, structure by analyzing the market segments and project the Nanomedicine Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Nanomedicine Market make the report investors guide.Scope of the Nanomedicine Market:

Nanomedicine Market by Modality:

Diagnostics TreatmentsNanomedicine Market by Diseases:

Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases Ophthalmological Diseases Immunological DiseasesNanomedicine Market by Application:

Neurology Cardiovascular Anti-Inflammatory Anti-Infectives OncologyNanomedicine Market by Region:

Asia Pacific North America Europe Latin America Middle East AfricaNanomedicine Market Major Players:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc Johnson & Johnson Mallinckrodt plc. Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Cytimmune Sciences, Inc.

Browse Full Report with Facts and Figures Report at:https://www.maximizemarketresearch.com/market-report/nanomedicine-market/39223/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Read the original here:
Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region - Good Night, Good Hockey

Read More...

New ‘molecular computers’ find the right cells – UW Medicine Newsroom

August 21st, 2020 11:59 am

Scientists have demonstrated a new way to precisely target cells by distinguishing them from neighboring cells that look quite similar.

Even cells that become cancerous may differ from their healthy neighbors in only a few subtle ways. A central challenge in the treatment of cancer and many other diseases is being able to spot the right cells while sparing all others.

In a paper published 20 August inScience FirstReleasea team of researchers at the University of Washington School of Medicine and theFred Hutchinson Cancer Research Centerin Seattle describe the design of new nanoscale devices made of synthetic proteins. These target a therapeutic agent only to cells with specific, predetermined combinations of cell surface markers.

Remarkably, these 'molecular computers' operate all on their own and can search out the cells that they were programmed to find.

"We were trying to solve a key problem in medicine, which is how to target specific cells in a complex environment," said Marc Lajoie, a lead author of the study and recent postdoctoral scholar at the UW MedicineInstitute for Protein Design. "Unfortunately, most cells lack a single surface marker that is unique to just them. So, to improve cell targeting, we created a way to direct almost any biological function to any cell by going after combinations of cell surface markers."

The tool they created is called Co-LOCKR, or Colocalization-dependant Latching Orthogonal Cage/Key pRoteins. It consists of multiple synthetic proteins that, when separated, do nothing. But when the pieces come together on the surface of a targeted cell, they change shape, thereby activating a sort of molecular beacon.

The presence of these beacons on a cell surface can guide a predetermined biological activity -- like cell killing -- to a specific, targeted cell.

The researchers demonstrated that Co-LOCKR can focus the cell-killing activity of CAR T cells. In the lab, they mixed Co-LOCKR proteins, CAR T cells, and a soup of potential target cells. Some of these had just one marker, others had two or three. Only the cells with the predetermined marker combination were killed by the T cells. If a cell also had a predetermined "healthy marker," then that cell was spared.

"T cells are extremely efficient killers, so the fact that we can limit their activity on cells with the wrong combination of antigens yet still rapidly eliminate cells with the correct combination is game-changing," said Alexander Salter, another lead author of the study and an M.D./Ph.D. student in the medical scientist program at the UW School of Medicine. He is training in Stanley Riddell's lab at the Fred Hutchinson Cancer Research Center.

This cell-targeting strategy relies entirely on proteins. This approach sets it apart from most other methods that rely on engineered cells and operate on slower timescales.

"We believe Co-LOCKR will be useful in many areas where precise cell targeting is needed, including immunotherapy and gene therapy," said David Baker, professor of biochemistry at the UW School of Medicine and director of the Institute for Protein Design.

Theresearch was conducted at the Institute for Protein Design, the Immunotherapy Integrated Research Center at the Fred Hutchinson Cancer Research Center, and the UW Department of Bioengineering.

The co-lead authors of this work are Marc J. Lajoie (supported by a Washington Research Foundation Innovation Postdoctoral Fellowship and a Cancer Research Institute Irvington Fellowship from the Cancer Research Institute), Scott E. Boyken (supported by the Burroughs Wellcome Fund Career Award at the Scientific Interface), and Alexander I. Salter (supported by the Hearst Foundation and Fred Hutchinson Cancer Research Center Interdisciplinary Training Grant in Cancer Research).

This work was also supported by the National Institutes of Health, National Science Foundation, the Defense Threat Reduction Agency, Nordstrom Barrier Institute for Protein Design Directors Fund, Hearst Foundation, Washington Research Foundation and Translational Research Fund, Howard Hughes Medical Institute, Open Philanthropy Project, and The Audacious Project organized by TED.

Several authors are inventors on patents related to this work. Some hold equity in Lyell Immunopharma. Some authors are now employees or consultants of Lyell Immunopharma.

This news release was written by Ian Haydon of the Institute for Protein Design.

Read the original here:
New 'molecular computers' find the right cells - UW Medicine Newsroom

Read More...

Subaru Taps Xilinx For Its New EyeSight Vision-Based Advanced Driver-Assistance System – Forbes

August 21st, 2020 11:58 am

Xilinx Automotive-Qualified (XA) Zynq UltraScale+ Multi-Processor System-On-A-Chip (MPSoC)

Auto makers have been continually updating and augmenting their vehicle line-ups with new, leading-edge technologies as they lay the foundation for future, fully-autonomous vehicles. Though the field is advancing rapidly, were not quite there yet. Technologies being introduced today, however, inch us ever closer to that fully-autonomous future and enhance current vehicles with additional capabilities to improve safety, comfort, or both.

Such is the case with Subaru and its upcoming Levorg. Subaru just announced that it has partnered with Xilinx to enable the Levorg with a leading-edge, vision-based ADAS system (Advanced Driver Assistance System) using stereo cameras, dubbed EyeSight. Subarus EyeSight system will enable new features like adaptive cruise control, lane-keep assist and pre-collision braking to name just a few.

At Subaru, we continuously strive to make the Subaru brand prominent in our customers hearts and minds by focusing our efforts on providing Enjoyment and Peace of Mind, and we believe ADAS is one of the technologies that will help us achieve that goal, said Tetsuo Fujinuki, chief technology officer, Subaru Corporation. Stereo cameras are at the heart of Subarus ADAS applications. Unlike common approaches, the image processing technology adopted in our new generation system scans everything captured by stereo cameras and creates high-precision 3D point clouds, enabling us to offer advanced features such as pre-collision braking at an intersection and assisting with hands-off driving in traffic congestion on a highway. Xilinx technology plays an important role in this. Because Xilinx automotive devices contain built-in capabilities that allow us to meet strict ASIL requirements, they are unquestionably the best technology to implement Subarus new ADAS vision system.

The Automotive Safety Integrity Level, or ASIL, is a risk classification system defined by the ISO 26262 standard for the functional safety of road vehicles.

Xilinx ADAS And AD Features

Subarus EyeSight system is built around the Xilinx Automotive-qualified (XA) Zynq UltraScale+ multi-processor system-on-a-chip (MPSoC). The XA Zynq UltraScale+ is a 16-nanometer product that enables high-speed data aggregation, pre-processing, and distribution (DAPD), as well as compute acceleration for L2+ to L4 ADAS and autonomous driving (AD) applications. The XA Zynq UltraScale+ is capable of processing stereo images and data captured by the Subaru EyeSight systems cameras and sensors into 3D point clouds with the low latency, which are used to dynamically react to the environment.

Xilinx Zynq UltraScale+ High-Level Block Diagram.

We are excited to see Xilinx automotive devices enabling the new generation of automotive safety for Subaru, said Yousef Khalilollahi, vice president of sales, Asia-Pacific region, Xilinx. Subarus name has long been synonymous with road safety and reliability, and were proud that our XA products have been selected to continue our shared vision of providing drivers with the most advanced safety features on the market.

The Subaru Levorg, featuring the auto makers next-gen EyeSight ADAS system will be available for pre-orders in Japan starting tomorrow (August 20).

Read more from the original source:
Subaru Taps Xilinx For Its New EyeSight Vision-Based Advanced Driver-Assistance System - Forbes

Read More...

Leading sight organizations to merge in fight to end global crisis in vision – Chinadaily USA

August 21st, 2020 11:58 am

James Chen is seen with children working on his philanthropic cause to give everyone access to vision correction if they need it. Photo provided to China Daily

Clearly, the eyesight charity set up by Chinese philanthropist James Chen, is to merge with the International Agency for the Prevention of Blindness next year in a bid to increase efforts in supporting better vision globally.

Over the last 15 years, Chen had made it his mission to tackle poor vision. He has been funding and leading work to promote universal access to glasses and said the merger is a step closer to his dream of helping the whole world see clearly.

The International Agency for the Prevention of Blindness, or IAPB, is a network of more than 150 members working in international eye health and leading global advocacy body for the sight sector.

The new partnership, which will come into effect on Jan 1,2021, was created to combine the two organizations' advocacy and campaigning expertise as a way to renew pressure on governments and global leaders to end the vision crisis.

In a report published in October, the World Health Organization said it would cost an estimated $14.3 billion to treat the 1 billion people already living with visual impairment or blindness from cataracts, and short and far-sightedness.

Chen said: "IAPB have long been a leader in the vision sector. I am delighted that we will be able to combine their unprecedented authority and reach within the sector with our ground-breaking campaigning work, particularly on school eye health, work-based sight tests and the links between vision and delivery of the Sustainable Development Goals."

Along with his ongoing interests as founder of Vision for a Nation and Adlens, Chen will play an even more active role in the vision sector following the merger, as a global ambassador for IAPB.

Peter Holland, chief executive of the IAPB, said that the unprecedented move marks the "next exciting phase in the battle to deliver vision for everyone".

"This is a hugely important development for the sector and comes at a time when poor vision is rising across the world," Holland said. "Clearly has made massive strides forward in waking up the world to the scale of the vision crisis. This merger will provide the IAPB with renewed vigor and expertise in effective campaigning. It will enable us to make the case even more effectively about the urgency and value for money of tackling the global vision crisis."

Read the original post:
Leading sight organizations to merge in fight to end global crisis in vision - Chinadaily USA

Read More...

Foresight: Eye-Net Mobile and Global Japanese Technology Company to Start Pilot Project – Business Wire

August 21st, 2020 11:58 am

NESS ZIONA, Israel--(BUSINESS WIRE)--Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd., will start a pilot project with a multi-billion dollar global Japanese technology company to test its Eye-Net Protect cellular-based V2X (vehicle-to-everything) accident prevention solution.

The pilot project will be used to validate the Eye-Net solution capabilities and its technical specifications. Upon successful completion, the Japanese technology company may proceed to commercial integration of the Eye-Net solution into its IoT platform which currently serves millions of users.

This pilot project marks an important milestone on Eye-Net Mobiles commercial roadmap. The technology company will be the first to evaluate the software development kit (SDK) configuration of Eye-Net Protect. Integration with a global Japanese company has the potential to allow our life-saving accident prevention solution to protect millions of users daily, said Dror Elbaz, COO & Deputy CEO of Eye-Net Mobile.

The Eye-Net Protect V2X solution is designed to protect the most vulnerable road users in real time - including pedestrians, cyclists, scooter drivers and car drivers - by providing collision alerts when the road users have no direct line of sight. An SDK configuration allows Eye-Net Mobile to integrate its solution with leading location-based products such as wearable devices, dashboard cameras, navigation aids, infotainment systems, third-party applications and other smart devices.

For more information about Eye-Net Mobile, please visit http://www.eyenet-mobile.com, or follow the Companys LinkedIn page, Eye-Net Mobile; Twitter, @EyeNetMobile1; and Instagram channel, Eyenetmobile1, the contents of which are not incorporated into this press release.

About ForesightForesight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the companys wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications. Foresights vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobiles cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients movement.

The companys systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the Advanced Driver Assistance Systems (ADAS), the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit http://www.foresightauto.com, follow @ForesightAuto1 on Twitter, or join Foresight Automotive on LinkedIn.

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses the terms of any agreement between Eye-Net and the global Japanese technology company, that the pilot project will be used to validate the Eye-Net solution capabilities and its technical specifications, that upon successful completion, the Japanese technology company may proceed to commercial integration of the Eye-Net solution into its IoT platform, and that potential integration with a global Japanese company has the potential to protect millions of users daily. Because such statements deal with future events and are based on Foresights current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Foresight's annual report on Form 20-F filed with the Securities and Exchange Commission ("SEC") on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third party websites.

Read this article:
Foresight: Eye-Net Mobile and Global Japanese Technology Company to Start Pilot Project - Business Wire

Read More...

Cheri McDaniel is almost 92, but that’s not slowing her down one bit – The Advocate

August 21st, 2020 11:58 am

Nearing 92, Cheri McDaniel is losing her eyesight. But her vision for new ideas is going strong.

Early this year, McDaniel finished her third book, and she says a fourth one might be on the way. On the West Feliciana Parish property where she is riding out the coronavirus pandemic with family members, she is creating plans for the gardens, ponds and structures she has built over the past five decades.

She also continues to raise money for charity work in Haiti and Swaziland through Rotary an organization she joined while creating a medical and educational mission in Mexico. She was only 75 then.

This likely surprises no one who knows McDaniel, who also has been a house designer, builder and antique store owner.

"I think her energy comes from her passions, either her passion to write, her passion to help others, her passion to serve," said Martha Stuckey, president of theCapital City Rotary Club, of which McDaniel is a member.

McDaniel suggests she doesnt deserve much credit.

Im a simple farm girl, she said. I feel that God is driving the vehicle of my life or I wouldnt still be here. These things just evolve.

Its been that way since McDaniel, who was born in 1928, grew up on a Union Parish farm through the Great Depression, earned a home economics degree and became a hospital dietitian. She met her first husband, Jack Smith, at LSU, and his oil industry work took them to El Dorado, Arkansas, and Memphis, Tennessee, before coming to Baton Rouge in 1947.

In each location, McDaniel designed the couple's home. Despite no formal education in construction or architecture, she discovered she had the ability to visualize a house and taught herself how to draw up plans that carpenters and other tradesmen could follow.

In Baton Rouge, she was a homemaker until their only child, Susan, was old enough to go to school. Since being a dietitian no longer appealed to her, she told Jack in 1958 that she was going to design and build homes for a living. She says she was the only woman to run such a company in Baton Rouge at the time and designed about 200 homes in 27 years.

I never did two houses alike, McDaniel said. Id meet with them, find out what they really wanted to have in a house, what was their budget, and it was my goal to be able to give them everything they wanted, and most of the time I was able to do that within their budget. And they left me alone.

Along the way, she founded Fireside Antiques in 1982, which Susan managed until becoming pregnant with quadruplets in 1986, so McDaniel took over and ran the business until 2003.

When she was in her mid-70s, sensing that God was calling her to the mission field, she moved to San Miguel de Allende, Mexico, and started the Holistic Educational Center, a facility that provided both medical care and education to improve the lives of impoverished residents there. She wrote grant applications that helped fund a retinopathy clinic at the local hospital there.

However, after four years, the 6,000-foot altitude was causing McDaniel fainting spells, and her second marriage was ending, so she returned to Baton Rouge. She joined the Capital City Rotary Club upon her return, writing grant proposals that created funding for outreach projects.

McDaniel moved to St. James Place retirement community. That's where she got the inspiration to write.

It began with her life story, titled He Lays the Stones for Our Steps, which she followed with Snazzy Seniors, telling stories of interesting and inspirational people she met. She sells the books through her Rotary club, and its proceeds go to club projects.

In her third book, Descending Toward Darkness, Illuminated by Faith, she tells the stories of people shes met who have come through challenges. God, she said, gave her the title. It was printed just before St. James Place went into lockdown in March, which McDaniel believes is no coincidence.

God had to have known that this pandemic was coming to give me such a strange title, she said. I wasnt planning to write a third book. I had never studied creative writing. So, God is still keeping me going.

The title also reflects some of McDaniels own experience.

A cancer survivor, she has faced numerous recent health challenges: congestive heart failure, shingles, knee surgery and failing eyesight that forced her to hand-write passages of the book in large letters so someone else could type them. She continues to write, currently focusing on spiritual topics.

I am now legally blind, but nothing seems to stop our heavenly father, she said. My writing has become a wonderful adventure.

One of many.

Every morning after breakfast, an assistant drives her in a golf cart for two hours to look over 388 acres near Lake Rosemound where McDaniel has built houses for family members and created a forest and garden from what was once a cow pasture.

McDaniel once held Easter sunrise worship services on the property and wanted to build a church there, but when the family didnt agree due to lack of suitable parking space, she built a small, open-air meditation chapel. Hundreds of encore azaleas bloom multiple times a year, creating vibrant color even in the August heat.

Its like I feel reborn in this environment, McDaniel said. Im still alive, and Im still being inspired by the infinite creator. I take no credit. His presence is so strong.

Read more here:
Cheri McDaniel is almost 92, but that's not slowing her down one bit - The Advocate

Read More...

Eyesight Technologies partners with GloboConnect to bring AI-driven safety to Oil & Gas Fleets – Geektime

August 21st, 2020 11:58 am

In the commercial fleet world, driver safety is above all, and it becomes even more crucial when a semi-trailer is hauling a couple of tons of dangerous or hazardous materials cross country. As weve witnessed in the past, the potential spills caused by the Oil & Gas industry fleets can cause immense environmental damage, if or when a mistake is made. Just the threat of a catastrophic oil spill hitting the news is poised to doom public opinion against the trucking company and supplier. Further highlighting the necessity for hazardous material drivers to stay alert and safe on the road, creating a potential problem that demands an innovative solution.

Israeli company Eyesight Technologies, which leverages AI and computer-vision technologies for a safe driving experience, announced that its partnering with French fleet management conglomerate GloboConnect, a leading provider of telematics systems for fleets.

"The partnership is a major part of our effort and investment to improve road safety," said Yannick GUIDEZ CEO of GloboConnect. "The addition of Eyesight Technologies' driver monitoring solution to our telematics capabilities enables us to extend our driver safety solutions to include monitoring inside the cabin, allowing our customers to ensure better driving practices and the safer transport of dangerous goods in the oil and gas trucking industry."

The joint venture will focus efforts towards developing a driver monitoring telematics device, tailored for the Oil & Gas industrys fleets. The device will combine Eyesight Technologies' computer vision and AI-based driver monitoring system (DMS) along with Globo's telematics infrastructure and hardware to improve road safety for an estimated 50,000 vehicles in oil & gas fleets.

"This partnership is another meaningful step towards creating safer driving environments in the fleet industry," said David Tolub, CEO of Eyesight Technologies. "An aftermarket DMS solution is a valuable addition to existing telematics offerings, increasing the safety and efficiency of fleets."

Read the original here:
Eyesight Technologies partners with GloboConnect to bring AI-driven safety to Oil & Gas Fleets - Geektime

Read More...

Heads or Tails – – The choice is up to you – – – Heads – Part #2 – GoErie.com

August 21st, 2020 11:58 am

Many of the animals, birds, and insects that are part of the Natural World have unique and useful uses and features related to their heads. This article covers a few of these which might explain such things as why a Dog tilt their heads when they hear a sound, and the Owl and the Praying Mantis are the only predators that have a special bone structure that is quite useful for them.

Now that I have covered Tails in article #1 let's move to the other half of our discussion on some of the unique features found in animals, birds, and insects in the natural world.

Just seeing a Dragonfly must be terrifying if you are a gnat, mosquito, or other small bugs. To us, humans, they are unique insects that are mostly quite nice to see. The eyes of a dragonfly take up 90% of its head. Their eyesight is the key to its hunting, and flying skills allow them to have a 95% success rate when hunting. They use this sight to judge the speed and trajectory of the target prey and adjust their flight to intercept the prey and snag it from the air.

The Common Mole's nose, found at the pointed end of its head, is the only part of its body it is not uncomfortable with. Despite devastating blindness and inadequate tactile sensitivity, the moles excel at finding food sources. Scientists have found that except for a few species of dogs such as the Bloodhound, which can tell the direction a smell comes from and follow it, the common mole may be the only animal with what is known as natural stereo smelling ability.

Look around, and maybe you can turn your head to the left or right and move it up and down with ease. You can also move your eyes around in many different directions, and a few of us can even cross our eyes. In the animal world, there are loads of various kinds of eyes that see the world in distinctive ways. Owls cannot move their eyeballs around in their sockets very well. Yet they do have particularly good night vision. Their eyes are positioned on the front of their heads like many of their fellow predators. They have what is thought of as binocular vision.

While Owls might not be able to move their eyeballs, they more this makeup for this by turning their heads up to 270 degrees to the right or left. That is more than twice what we humans can do. The owls have what is called a pivot joint in their bone structure that allows this broad range of movement. There is only one other predator that can do this. It is the Praying Mantis.

What is magnetite? It is a naturally occurring mineral that reacts to magnetic fields. Scientists believe that many animals may have small amounts of it in their brains, allowing them to sense the magnetic fields produced by the earth. However, Dolphins and some whales have magnetic rocks in their heads. Bats and birds (especially pigeons) can navigate vast distances without any clues as to where they are other than the presence and shape of the magnetic fields, which they sense using the magnetite in their brains. Dolphins and many species of whalecan navigate enormous miles of open ocean by using these same, but larger, rocks of this substance within their brains. They are navigating by the magnetic fields they have used during their entire life. They may even think they are in the open and deep waters but can be dangerously close to the shore.

Have you ever noticed that many species of Birds head-bob when they are walking? The term head-bobbing is used for the apparent back and forth movement of their head as they walk and is a bit of a misnomer. The birds do not bob their heads, ---instead, they move their body forward and leave their head behind. They then thrust their head forward past their body. This crazy behavior is thought to help critical aspects of their vision during their forward movement.

If you happen to see a deer bobbing its head, it is not like a bird. A deer's pupils are not like humans; instead, they are more oval and oriented horizontally to give them a wider field of view. We humans can see about a 120-degree range of vision. Having their eyes on the side of their head plus having the oblong pupils, a deer has close to a 300 degrees range. While this gives them a wider angle of vision, it does impact their vertical sight. That is one reason hunters sometimes use a tree stand. Because of this vertical limit, they bob their head to improve their vertical vision.

When you are out on Presque Isle, I am willing to bet that many of my readers think they see an eagle flying overhead. Well, most times, you have spotted a turkey vulture and not an eagle. While looking somewhat like an eagle, they have a genuine bald head while the eagle has white feathers. At close range, they resemble the wild turkey, hence their name. They are the only scavenger bird that cannot kill their prey. This is because their feet are like chickens and not an eagle's or a hawk's. Instead, they have a powerful beak that can tear through even the most robust cowhide. They also have an extraordinary sense of smell that allows them to locate a dead animal from over a mile away.

Monkeys use faces like name tags. They all boast the most colorful faces in the mammal kingdom, and they are not just for show. Like humans, they distinguish friend or foe by facial features, which have evolved to be uniquely distinctive in their close-knit communities.

Why do dogs tilt their heads when they hear sounds. The human ear is engineered to pick up a sound so efficiently that you do not need to turn toward the sound to capture it. That is not so with a dog. Dogs have flaps that partially or entirely cover the ear canal and serve as a barrier to sound. Luckily, the canine ear flap is moveable so the dog can easily make the necessary adjustment and tilt its head toward the sound.

Rabbit ears have a unique shape. Yes, they are long. However, they also have a curve that turns them into satellite dishes place upon a bunny's head. Their shape helps catch and amplify all sounds. Because rabbits are prey species, they must continuously monitor for small sounds that may show a predator is near. They also need to know where the sound is coming from. The length and their ability to move, turn and tilt their ears give rabbits a directional location of the sound. They also use their ears to signal other rabbits. People who have rabbits often tell that rabbits "waggle" their ears at their humans to get interaction from them.

In ending, I know there are many more different and interesting facts about animals, and I may in the future gather in some others and post here on Goerie.com.

See you on the park!!

Gene Ware is a published author of 9 books and is on the boards of the Presque Isle Light Station and was past Chairman of the Tom Ridge Center Foundation, and the Presque Isle Partnership. He is also a goerie.com contributing writer. Send questions and comments to ware906@gmail.com

Read more:
Heads or Tails - - The choice is up to you - - - Heads - Part #2 - GoErie.com

Read More...

Bronx son survived gunshot wound to head, but recovery took its toll, and his life – WPIX 11 New York

August 21st, 2020 11:58 am

QUEENS A Bronx mother, who watched her only son rally from a gunshot wound to the head on July 4, 2019, mourned his loss outside the Queens rehab center where he spent the final months of his life.

He lived this for 13 months, Nicole Backmon said of her son Sammy, 21, outside the Park Terrace Care Center in Corona, Queens. He was a warrior.

Sammy Backmon was one face of gun violence in a city where most victims dont make headlines.

At age 20, he suffered a traumatic brain injury when he was hit by a bullet while coming home to the family apartment on Hull Avenue in the Bronx; he was celebrating the Fourth of July holiday.

He was walking home from the train and shots were fired, his uncle, Alex Rodriguez, said, and he got hit in the back of the head.

Sammy Backmon spent weeks in the intensive care unit at St. Barnabas Hospital, where he suffered brain damage that affected his speech, memory, mobility and eyesight.

The vision was really, really bad, Sammys uncle recalled. He couldnt see anything, except for a blurry silhouette.

But the family said Sammy Backmon improved remarkably after spending two months at Burke Rehab in White Plains. He was later transferred to the facility in Queens that accepted Medicaid payments.

His vision gradually got much better.

In February, wearing a helmet on his damaged skull, family cell phone videos showed physical therapists helping Sammy Backmon to start walking again.

He was almost walking independently, his mother said.

But the young man was having recurring issues with blood clots and circulation.

He made it through the height of the COVID-19 pandemic in new York without getting sick, but it did have an impact on his general health.

When COVID hit, PT really slowed down, Sammys uncle recalled. He started gaining weight, he wasnt moving, his circulation wasnt good.

Surgery to put a steel plate in Sammy Backmons head was repeatedly delayed.

On June 26, Sammy Backmon enjoyed a reunion with his extended family, dining outdoors in the Bronx after a visit to a medical clinic there.

His uncle took videos, joking it was Quarantine Friday, while one of Sammy Backmons little cousins ran around the table.

In late July, Sammy Backmon finally underwent the surgery to put the plate in his head where a piece of his skull used to be.

The family said it was a success.

But on August 10, Nicole Backmon got a call she wasnt prepared for.

Sammy Backmon, her only son, was dead at 21.

They think he had a seizure, Nicole Backmon said.

Sammy Backmons death certificate said he died of complications from a gunshot wound. His family wants an autopsy performed, and theyve started a GoFundMe page to defray funeral expenses.

His mother wants the public to know he endured a lot during the months he spent in a long-term care facility.

My son suffered in silence, Nicole Backmon said. He didnt tell me everything.

Read more from the original source:
Bronx son survived gunshot wound to head, but recovery took its toll, and his life - WPIX 11 New York

Read More...

Amazons latest Fire TV feature is designed to assist the visually impaired – TrustedReviews

August 21st, 2020 11:57 am

If you have problems with your eyesight and struggle to watch a lot of TV, Amazons latest update to its Fire TV platform could help resolve those issues.

Amazon has announced Text Banner for its Fire TV platform. Its an assistive technology designed for those with visual impairments and narrow field of vision, including conditions such as macular degeneration, glaucoma and retinitis pigmentosa.

Text Banner works by consolidating the onscreen text of a selected item/icon into a compact, rectangular banner that appears in a fixed location on the screen.

The entire Fire TV user interface, Prime Video and all apps on Fire TV work with Text Banner, which Amazon says makes it easier for these customers to enjoy movies, videos. Users can customise the feature by the changing colours as well as the size of the box and the text bu heading to Settings> Accessibility > Text Banner.

Marc Powell, Strategic Accessibility Lead at RNIB, said: The accessibility of tech is changing the lives of blind and partially sighted people giving a greater sense of freedom, increasing independence and breaking down barriers to create a more inclusive world.

Amazons move to begin making its Fire TV platform more accessible for people with vision impairment is another powerful message of inclusivity to the industry and we hope to continue seeing accessibility improve as a trend across the technology sector in the years ahead.

The Text Banner feature is available now. The cheapest available Fire TV Stick costs 44.99. Prime Video costs 7.99/month or you can get it as part of a Prime Membership, which costs 79/year.

TV & Audio Editor

Kob began his career at What Hi-Fi?, starting in the dusty stockroom before rising up the ranks to join the editorial and production team as the Buyers Guide editor. Experienced in both magazine and

Unlike other sites, we thoroughly review everything we recommend, using industry standard tests to evaluate products. Well always tell you what we find. We may get a commission if you buy via our price links.Tell us what you think email the Editor

Read the original:
Amazons latest Fire TV feature is designed to assist the visually impaired - TrustedReviews

Read More...

Bird deaths from wind turbine’s drop when one blade is painted black – PoliticalLore.com

August 21st, 2020 11:57 am

The problem of mass death of birds from a wind turbine could be resolved through painting one blade black. That makes it easier for birds to avoid a deadly encounter, say the findings published in Ecology and Evolution.

The recent study found that painting one of the four white blades on a wind turbine black significantly decreases the number of dead birds by 72 per cent.

In fact, wind farms would kill twice as many bats as they do birds, the figures would be: 111 333 birds per turbine per year, and 222 666 bats per turbine/year, according to Mark Duchamp, head of Save the Eagles International.

According to the researchers from the Norwegian Institute for Nature Research conducted a trial on the remote island of Smola comparing how many birds were killed by four painted turbine compared to their untouched neighbours.

During seven and half years, the researchers regularly scoured the bottom of the turbines with specially trained sniffer dogs to identify any bird carcasses. The difference between periods when one of the four blades was painted black was impressive.

For the eight turbines included in the research four painted and four left bare a total of 1,275 searches were conducted between 2006 and 2016.

A total of 82 carcasses were found and statistical analysis revealed the birds which benefit the most from the pained blades are raptors and large soaring birds.

This includes eagles and vultures, who have been high-profile casualties of wind turbines. No white-tailed eagle carcasses were recorded after painting the blades.

The study also found that while the number of dead birds dropped at painted turbines, it did not trigger a spike in the number of casualties at neighbouring turbine zones. As the scientists suggest, the reason painting a single blade works is due to a phenomenon called motion smear.

This means that, although birds often have exceptional eyesight, the rotating blades appear invisible. Birds have extremely high-resolution eyesight in their peripheral field of vision, and the front-facing eyesight is not as good.

Thus, within assumed open airspace, birds may therefore not always perceive obstructions ahead thereby enhancing the risk of collision, the study says.

See original here:
Bird deaths from wind turbine's drop when one blade is painted black - PoliticalLore.com

Read More...

To Win, Decide Which Fear You Can Live With – Forbes

August 21st, 2020 11:57 am

Author and Motivational Speaker, Chad Foster

Chad Fosters life took a detour when he went blind in his late teens. Now hes an executive at Red Hat, the worlds largest open source software company, an author, and a motivational keynote speaker. His memoir, Blind Ambition (published by HarperCollins Leadership), will publish in early 2021.

I had the opportunity to interview Chad recently. Here are some of the highlights of that interview:

Jill Griffin: Take us back to when you lost your sight

Chad Foster: I was studying at the University of Tennessee when my eyesight really began fading. I was diagnosed at three-years-old with retinitis pigmentosa, a genetic eye condition, and doctors told my parents Id eventually go blind.

For me, it was really just an intellectual concept, because I played sports, drove a car, and other things people take for granted. I thought maybe Id be an outlier, but my eyesight started failing in college. Going blind changed the course of my life. It was a pretty dark time, but the fire inside of me didnt flame out.

Griffin: It must have been a challenging period. What was your response?

Foster: It was dreadful. Beyond the striking emotional challenges, I was a visual learner, which wasnt useful as a blind guy. So I changed my major from pre-medicine to business. My mom read all of my business books to tape, I recorded the lectures, and I listened to the books and lectures multiple times. It turned out I was a better blind student than sighted student. I made straight A's and the Deans List, and upon graduation moved to Atlanta to work for Anderson Consulting (currently Accenture). I was terrified my support system was gone, I didn't know Atlanta, I was working in an industry requiring significant travel. Ultimately, I had to decide which fear I could live with. The fear of failing, or the fear of not knowing my potential.

Griffin: So you became more comfortable with the fear?

Foster: I learned to get comfortable with discomfort. When I was in college, my well-intended parents built a basement for me, just in case I didn't make it in the world. I started thinking of it as the loser basement, and vowed to never spend a day there. If we let others control our expectations for ourselves, whether that be our well-meaning parents or society, where will we end up? We need to live life based on our own vision of greatness.

Griffin: Andersen Consulting is a prestigious Fortune 500 company. What do you think made them seek you out?

Foster: Outstanding companies look for intelligence, drive and a willingness to try. When I explained my journey during the interview, any doubts about my determination were extinguished. In tech its easy to find a developer, but skills have a short shelf life because what will technologies look like in ten years? Whats important is finding people who are smart, naturally curious, and determined. The landscape changes so quickly that hiring for skills is less durable than hiring for traits.

Griffin: Tell me about the software you developed that Oracle said was impossible?

Foster: I taught myself to engineer my own software, and I got so good at it that people would seek me out. One day a colleague called. They had a customer with a blind employee who couldnt do his job because of a problem between their customer relationship management software and screen-reading software.-

So, I said, Yeah, I'll talk to the client, and then I started doing what I always do, which is dig for a solution.

A year or two later, I got an email asking for help with Siebel, and I responded casually saying, I've done this before.

So, we all hopped on a call me, the prospective client and their technical account manager from Oracle, the vendor of the screen-reading software, and my former client and they said, Weve talked to Oracle and the maker of the screen-reading technology and, it's not possible. And then my client said, Actually, Chad's already done it, and I've been using the technology for the last two years. Oracle started sending me clients after that.

Griffin: You were the first blind graduate of the Harvard Business Schools Program for Leadership Development. What did you learn there?

Foster: There are no black and white answers in the world of leadership. Weve got to think about and manage shades of grey. We explored the nuances of real-world business cases and observed them from many different vantage points. I learned a lot from the faculty, as well as my fellow executive classmates.

Griffin: Youre publishing your first book. Can you tell me about that?

Foster: Blind Ambition is a memoir, because the best way for people to digest the lessons Ive learned is to hear the stories from my life. Fundamentally, we all become the stories that we tell ourselves. Its about how I learned resilience by attending the school of hard knocks, being able to distinguish whats inside my sphere of influence, such as my ability to use a computer, write code, and get on stage and deliver an inspirational keynote without notes, and learning how to accept and even embrace things that are outside my sphere.

If you tell yourself youre a victim, that's how youll be. If you tell yourself I've got this, I'm owning this blindness thing, and Ill make it look good, then that's how youll be. And its a self-fulfilling prophecy, because we all become the stories playing in our minds. We can choose to move our mindset from victim to visionary.

We have to be prepared to reinvent ourselves. My blindness came in terrible wrapping paper, but its a gift that enables me to help others in a way thats not otherwise possible.

Griffin: What are some of the major themes that you touch on in your workshops?

Foster: The number one pillar is dealing with change. When going blind, I had to deal with the loss of my self-identity. I never aspired to grow up and be a blind guy, so I had to create a vision of greatness that included my blindness. All of us have faced the question what do you want to be when you grow up? No one said, I want to be a blind guy. But when life changes, we have to figure out how to visualize success. Now, I provide a framework for building resilience. Creating some space to be mindful and intentional about that allows us to respond to challenges more effectively. Coupled with strategy, effort, determination and a plan, its a winning formula.

Griffin: What inspired you to give motivational keynotes in front of thousands of people?

Foster: My tipping point was giving the graduation speech at Harvard. I had a feeling Id be elected so, being a Type-A personality, I met with a professional speaker and prepared my talk before we even voted. When I was elected, I delivered a very moving keynote. One classmate was so moved that he decided to commission an opera inspired by my story. Several others shared how Id inspired them as they faced traumatic situations. I was also moved a feeling of electricity coursed through my body, and I knew I was doing the right thing. At that point I saw how powerfully I could help others if I were to be intentional about it.

Excerpt from:
To Win, Decide Which Fear You Can Live With - Forbes

Read More...

Page 441«..1020..440441442443..450460..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick